Obesity, body composition and metabolic disturbances in polycystic ovary syndrome

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. / Svendsen, Pernille Fog; Nilas, Lisbeth; Nørgaard, Kirsten; Jensen, Jens-Erik Beck; Madsbad, Sten.

In: Human Reproduction, Vol. 23, No. 9, 2008, p. 2113-21.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Svendsen, PF, Nilas, L, Nørgaard, K, Jensen, J-EB & Madsbad, S 2008, 'Obesity, body composition and metabolic disturbances in polycystic ovary syndrome', Human Reproduction, vol. 23, no. 9, pp. 2113-21. https://doi.org/10.1093/humrep/den211, https://doi.org/10.1093/humrep/den211

APA

Svendsen, P. F., Nilas, L., Nørgaard, K., Jensen, J-E. B., & Madsbad, S. (2008). Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Human Reproduction, 23(9), 2113-21. https://doi.org/10.1093/humrep/den211, https://doi.org/10.1093/humrep/den211

Vancouver

Svendsen PF, Nilas L, Nørgaard K, Jensen J-EB, Madsbad S. Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. Human Reproduction. 2008;23(9):2113-21. https://doi.org/10.1093/humrep/den211, https://doi.org/10.1093/humrep/den211

Author

Svendsen, Pernille Fog ; Nilas, Lisbeth ; Nørgaard, Kirsten ; Jensen, Jens-Erik Beck ; Madsbad, Sten. / Obesity, body composition and metabolic disturbances in polycystic ovary syndrome. In: Human Reproduction. 2008 ; Vol. 23, No. 9. pp. 2113-21.

Bibtex

@article{46ee97c004ca11deb05e000ea68e967b,
title = "Obesity, body composition and metabolic disturbances in polycystic ovary syndrome",
abstract = "BACKGROUND: We determined the impact of polycystic ovary syndrome (PCOS) and obesity on glucose and lipid metabolism and beta-cell function in women with PCOS. METHODS: In 35 women with PCOS (17 lean, lean PCOS and 18 obese, obese PCOS) and 25 control women (9 lean, lean controls and 16 obese, obese controls), beta-cell function was evaluated by the first-phase insulin response after intravenous glucose, acute insulin response to glucose (AIRg); insulin sensitivity, determined as insulin sensitivity index (ISI), was evaluated by the euglycemic hyperinsulinemic clamp. Indirect calorimetry was used for the assessment of glucose and lipid oxidation. Body composition was estimated by dual X-ray absorptiometry scan. RESULTS: When adjusted for obesity, PCOS was associated with higher 2-h glucose levels (P < 0.05), higher trunk/periphery fat ratio (P < 0.001), lower ISI (P < 0.001), lower insulin-stimulated glucose oxidation (GOX 2) (P < 0.05) and lower non-oxidative glucose metabolism (P < 0.05), but a normal AIRg compared with control women. Lean women with PCOS had lower ISI (P < 0.001), GOX-2 (P < 0.05) and higher trunk/periphery fat ratio (P < 0.05) than lean control women. In obese women with PCOS, ISI was reduced with 25% compared with obese control women, whereas trunk/peripheral fat ratio did not differ. AIRg was increased in obese groups compared with lean groups (P < 0.05), but was, in all groups, appropriate for the ambient action of insulin. CONCLUSIONS: PCOS is associated with a low ISI, which in lean women with PCOS may partly be explained by higher trunk/peripheral fat ratio. AIRg was amplified by obesity, but was, in all groups, appropriate for prevailing insulin sensitivity, suggesting a normal beta-cell adaptation.",
author = "Svendsen, {Pernille Fog} and Lisbeth Nilas and Kirsten N{\o}rgaard and Jensen, {Jens-Erik Beck} and Sten Madsbad",
year = "2008",
doi = "10.1093/humrep/den211",
language = "English",
volume = "23",
pages = "2113--21",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "Oxford Academic",
number = "9",

}

RIS

TY - JOUR

T1 - Obesity, body composition and metabolic disturbances in polycystic ovary syndrome

AU - Svendsen, Pernille Fog

AU - Nilas, Lisbeth

AU - Nørgaard, Kirsten

AU - Jensen, Jens-Erik Beck

AU - Madsbad, Sten

PY - 2008

Y1 - 2008

N2 - BACKGROUND: We determined the impact of polycystic ovary syndrome (PCOS) and obesity on glucose and lipid metabolism and beta-cell function in women with PCOS. METHODS: In 35 women with PCOS (17 lean, lean PCOS and 18 obese, obese PCOS) and 25 control women (9 lean, lean controls and 16 obese, obese controls), beta-cell function was evaluated by the first-phase insulin response after intravenous glucose, acute insulin response to glucose (AIRg); insulin sensitivity, determined as insulin sensitivity index (ISI), was evaluated by the euglycemic hyperinsulinemic clamp. Indirect calorimetry was used for the assessment of glucose and lipid oxidation. Body composition was estimated by dual X-ray absorptiometry scan. RESULTS: When adjusted for obesity, PCOS was associated with higher 2-h glucose levels (P < 0.05), higher trunk/periphery fat ratio (P < 0.001), lower ISI (P < 0.001), lower insulin-stimulated glucose oxidation (GOX 2) (P < 0.05) and lower non-oxidative glucose metabolism (P < 0.05), but a normal AIRg compared with control women. Lean women with PCOS had lower ISI (P < 0.001), GOX-2 (P < 0.05) and higher trunk/periphery fat ratio (P < 0.05) than lean control women. In obese women with PCOS, ISI was reduced with 25% compared with obese control women, whereas trunk/peripheral fat ratio did not differ. AIRg was increased in obese groups compared with lean groups (P < 0.05), but was, in all groups, appropriate for the ambient action of insulin. CONCLUSIONS: PCOS is associated with a low ISI, which in lean women with PCOS may partly be explained by higher trunk/peripheral fat ratio. AIRg was amplified by obesity, but was, in all groups, appropriate for prevailing insulin sensitivity, suggesting a normal beta-cell adaptation.

AB - BACKGROUND: We determined the impact of polycystic ovary syndrome (PCOS) and obesity on glucose and lipid metabolism and beta-cell function in women with PCOS. METHODS: In 35 women with PCOS (17 lean, lean PCOS and 18 obese, obese PCOS) and 25 control women (9 lean, lean controls and 16 obese, obese controls), beta-cell function was evaluated by the first-phase insulin response after intravenous glucose, acute insulin response to glucose (AIRg); insulin sensitivity, determined as insulin sensitivity index (ISI), was evaluated by the euglycemic hyperinsulinemic clamp. Indirect calorimetry was used for the assessment of glucose and lipid oxidation. Body composition was estimated by dual X-ray absorptiometry scan. RESULTS: When adjusted for obesity, PCOS was associated with higher 2-h glucose levels (P < 0.05), higher trunk/periphery fat ratio (P < 0.001), lower ISI (P < 0.001), lower insulin-stimulated glucose oxidation (GOX 2) (P < 0.05) and lower non-oxidative glucose metabolism (P < 0.05), but a normal AIRg compared with control women. Lean women with PCOS had lower ISI (P < 0.001), GOX-2 (P < 0.05) and higher trunk/periphery fat ratio (P < 0.05) than lean control women. In obese women with PCOS, ISI was reduced with 25% compared with obese control women, whereas trunk/peripheral fat ratio did not differ. AIRg was increased in obese groups compared with lean groups (P < 0.05), but was, in all groups, appropriate for the ambient action of insulin. CONCLUSIONS: PCOS is associated with a low ISI, which in lean women with PCOS may partly be explained by higher trunk/peripheral fat ratio. AIRg was amplified by obesity, but was, in all groups, appropriate for prevailing insulin sensitivity, suggesting a normal beta-cell adaptation.

U2 - 10.1093/humrep/den211

DO - 10.1093/humrep/den211

M3 - Journal article

C2 - 18556679

VL - 23

SP - 2113

EP - 2121

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 9

ER -

ID: 10870826